 
LUPIN LIMITED 
Registered Office: 3rd Floor, Kalpataru Inspire, Off W. E. Highway, Santacruz (East), Mumbai - 400 055 India. Tel: (91-22) 6640 2323.  
Corporate Identity Number: L24100MH1983PLC029442                                                                      info@lupin.com | www.lupin.com 
 
 
 
 
 
 
 
November 21, 2025 
 
National Stock Exchange of India Limited 
Exchange Plaza, 
Bandra Kurla Complex, 
Bandra (East),  
Mumbai - 400 051 
BSE Limited 
P. J. Towers, Dalal Street, 
Mumbai Samachar Marg, 
Mumbai - 400 001 
Symbol: LUPIN Scrip Code: Equity - 500257 
 
Subject: Disclosure pursuant to Regulation 30 of the Securities and Exchange Board of India 
(Listing Obligations and Disclosure Requirements) Regulations, 2015 (‘SEBI Listing 
Regulations’)  
 
Dear Sir/Madam, 
 
We would like to inform you that the U.S. FDA has conducted an inspection at our manufacturing facility 
located at Goa, India. The Inspection was conducted from November 10 to November 21, 2025 and closed 
with the issuance of a Form-483 with seven observations.  
 
We will address the observations  and respond to the U.S. FDA within the stipulated timeframe. We are 
committed to be compliant with CGMP standards across all our facilities. 
 
This may kindly be considered as a disclosure pursuant to Regulation 30 of the SEBI Listing Regulations. 
 
Thanking you, 
 
For LUPIN LIMITED 
 
 
 
 
AMIT KUMAR GUPTA 
COMPANY SECRETARY & COMPLIANCE OFFICER 
(ACS -15754) 
 
 
 
